Pre-market hot trades in US stocks: Liminatus Pharma up 17.00% in pre-market; Masterbeef down 13.79% in pre-market

Pre-market Hot Trades in US Stocks Liminatus Pharma is up 17% in pre-market trading. Based on recent key news: On February 9, Liminatus Pharma reached a settlement agreement with Clear Street LLC to issue 4 million shares of common stock in exchange for the cancellation of 805,377 warrants. This move reduces legal and financial burdens, although it dilutes equity for existing shareholders, it eliminates significant legal risks and drives the stock price up. On February 9, Liminatus Pharma released relevant information through the EDGAR system to ensure transparency and enhance market confidence. The company's activities in the pharmaceutical and biotechnology sectors, as well as its relationship with the US capital markets, further support the positive performance of the stock price. On February 9, technical sentiment signals indicated a sell, but the market's positive reaction to the company's resolution of legal issues caused the stock price to rise against the trend. The pharmaceutical industry has been volatile recently and requires attention. Masterbeef is down 13.79% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. Top Gainers in Pre-market US Stocks Lianhe Sowell is up 63.29% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. ChowChow Cloud is up 56.55% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. Fastly is up 38.99% in pre-market trading. Based on recent key news: On February 11, Fastly announced its fourth-quarter earnings report, exceeding expectations with an EPS of $0.12, far surpassing the estimated -$0.03, driving the stock price up. Revenue increased by $32.03 million year-on-year, demonstrating strong financial performance. Source: Benzinga On February 12, William Blair analyst Jonathan Ho gave Fastly a buy rating with a target price of $10.80, boosting market confidence. Source: Benzinga On February 12, Fastly announced a full-year revenue forecast of $700 million to $720 million, a 15% increase from last year, and expects adjusted profits for the first quarter of 2026 to be $0.07 to $0.10 per share, exceeding analyst expectations. Source: Benzinga The technology industry is experiencing strong growth, driven by AI demand